14.12.2011
MagForce Signs Letter of Intent with Leading Russian Medical Product Distribution Company Delrus
Plans outlined for NanoTherm® therapy market entry in Russia Financial and professional support for approval in RussiaFirst step for internationalization of NanoTherm® therapy Berlin, December 14, 2011 - MagForce AG (XETRA:MF6), a leading medical technology company focusing on ...
22.11.2011
MagForce AG Announces Initiation of Research Coverage by Merchant Securities Limited
Berlin, November 22, 2011 - MagForce AG (FSE:MF6), a leading medical technology company focusing on nanomedicine in oncology, announced today that Merchant Securities Limited has initiated research coverage on the company and published its first report today. The report is available upon ...
17.11.2011
MagForce AG Shareholders' Letter
Dear Shareholders, Today we would like to give you an update on the most important developments at MagForce since the beginning of this year. We are pleased to inform you that leading experts have shown a strong interest in NanoTherm® therapy for the treatment of brain tumors and are ...
31.10.2011
MagForce AG Announces Changes to Supervisory and Management Boards
Berlin, October 31, 2011 - MagForce AG (FSE:MF6), a leading medical technology company focusing on nanomedicine in oncology, announced today the resignation of Prof. Dr. Walter Rust as chairman of the Supervisory Board as of October 25, 2011 due to health reasons. Effective October 28, 2011, Dr. ...
10.10.2011
MagForce AG Announces Treatment of Recurrent Glioblastoma Patient with NanoTherm® Therapy
Patient treated at the University of Giessen and Charité University Medical Center Berlin in an interdisciplinary cooperationThe first treatment approvals have been received from German state insurance companies Berlin, October 10, 2011 - MagForce AG (FSE:MF6), a leading medical technology company ...
19.09.2011
MagForce AG Completes Share Placement
Announcement in accordance with section 17 para. 2 of the General Terms and Conditions of Deutsche Börse AG for the Regulated Unofficial Market on the Frankfurt Stock Exchange Berlin, Sept 19, 2011 - MagForce AG (FSE:MF6), a leading medical technology company focusing on nanomedicine in oncology, ...
18.07.2011
MagForce Nanotechnologies AG Announces Establishment of NanoTherm® Therapy Treatment Center at Charité University Medical Center
Berlin, July 8, 2011 - MagForce Nanotechnologies AG (FSE:MF6), a leading medical technology company focusing on nano medicine in oncology, announced today that the Charité-Universitätsmedizin Berlin published the establishment of its NanoTherm® therapy center for the treatment of recurrent brain ...
